SHYNDEC(SH:600420) Sou Hu Cai Jing·2025-07-31 19:31Summary of Key Points Core Viewpoint - The company, Guoyao Modern, is undergoing a significant transaction involving the transfer of a 51% stake in Shanghai Modern Harsen Pharmaceutical Co., Ltd. The transaction is not classified as a major asset restructuring and is expected to impact the company's financial reporting structure post-completion [2][4]. Trading Information - As of July 31, 2025, Guoyao Modern's stock closed at 11.47 yuan, reflecting a decrease of 0.95%. The turnover rate was 2.33%, with a trading volume of 312,400 shares and a total transaction value of 361 million yuan [1]. - On the same day, the net outflow of main funds was 16.986 million yuan, accounting for 4.71% of the total transaction value. In contrast, retail funds saw a net inflow of 4.7 million yuan, representing 1.3% of the total transaction value [2][4]. Company Announcement - Guoyao Modern announced the public transfer of its 51% stake in Shanghai Modern Harsen Pharmaceutical Co., Ltd. at a base price of 155.192541 million yuan. The transaction does not constitute a major asset restructuring, and the details regarding the transaction counterpart, price, and timing are yet to be determined [2][4]. - As of April 30, 2025, Shanghai Modern Harsen reported total assets of 339.1778 million yuan, total liabilities of 187.15 million yuan, and owner’s equity of 152.0278 million yuan. The revenue for the first four months of 2025 was 100.7613 million yuan, with a net loss of 19.898 million yuan [2]. - The assessed value of the total equity of Shanghai Modern Harsen is 304.2991 million yuan, indicating a value increase of 100.16% [2].